Completed PHASE2 INTERVENTIONAL 2-arm NCT02526576

Adipose Derived Stem Cells in Facial Fat Grafting (SVF)

A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)

Sponsor: Antria

Conditions Facial Atrophy

Interventions Biopsy Stromal Vasular Fraction

Updated 8 times since 2017 Last updated: Feb 25, 2019 Started: Aug 31, 2015 Primary completion: Jul 31, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Facial Atrophy and is currently completed. Antria leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Mar 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jun 2018 — Mar 2019 [monthly]

Unknown Status PHASE2

▶ Show 3 earlier versions

Oct 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Feb 2017 — Oct 2017 [monthly]

Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Antria

Data source: Antria

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Delmont, United States